Continuous Outcome Estimation in N-of-1 Trials for Accelerated Decision-Making
Defelippe, V.; Bartos, F.; Wagenmakers, E.-J.; Braun, K. P. J.; Jansen, F. E.; Otte, W. M.
Show abstract
N-of-1 trials aim to determine the therapeutic effect for a single individual. This individualized approach necessitates collecting multiple data points over time through repeated alternating periods of active treatment and a comparator or control condition. The extended duration of the treatment periods may increase patient burden, prolong placebo exposure, and increase the likelihood of study discontinuation. In theory, treatment responders (or non-responders) can be identified early during the trial if the therapeutic effect is strong (or completely lacking). There are no theoretical constraints to evaluate treatment efficacy more regularly - not only after a predetermined number of treatment periods - given that the individualized character of the N-of-1 study permits a statistical model update as soon as new data becomes accessible. Regularly updating estimates on treatment effects allows clinicians to accelerate clinical decision-making regarding N-of-1 study termination. This study examines the importance of continuous treatment effect estimation in N-of-1 trials through simulation and re-analysis of existing trial datasets of neurological diseases. Results indicate that treatment efficacy decisions can be expedited when outcome estimation is performed continuously rather than delayed until the end of the trial.
Matching journals
The top 8 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- Comparing randomized trial designs to estimate treatment effect in rare diseases with longitudinal models: a simulation study showcased by Autosomal Recessive Cerebellar Ataxias using the SARA score 93%
- Comparison of Bayesian networks, G-estimation and linear models to estimate causal treatment effects in aggregated N-of-1 trials 91%
- Prediction-powered Inference for Clinical Trials 90%
Similar papers in this journal
- On-Demand Seizures Facilitate Rapid Screening of Therapeutics for Epilepsy 92%
- Pallidal neuromodulation of the explore/exploit trade-off in decision-making 92%
- NBI-921352, a First-in-Class, Na V 1.6 Selective, Sodium Channel Inhibitor That Prevents Seizures in Scn8a Gain-of- Function Mice, and Wild-Type Mice and Rats 91%
Similar papers in this journal
- Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: a scoping review 91%
- Using simulated infectious disease outbreaks to guide the design of individually randomized vaccine trials 89%
- Estimating Counterfactual Placebo HIV Incidence in HIV Prevention Trials Without Placebo Arms Based on Markers of HIV Exposure 89%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.